LPBI Management | Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA

The Founder is a UC, Berkeley PhD’83 who had worked at Director Level for SRI Int’l, MITRE, PSC, McGraw Hill. Other employer organizations includes: Monitor Company (now Deloitte), Amdahl Corporation (now Fujitsu), PSC (now Dell Technologies). Positions in Healthcare are described in this link: http://Scientific and Medical Affairs Chronological CV

Aviva Lev-Ari, PhD, RN

Director & Founder

https://lnkd.in/eEyn69r

Picture date: 2/6/2022

While you are reviewing LPBI Group’s Portfolio of IP assets

https://pharmaceuticalintelligence.com/portfolio-of-ip-assets/

you will note that LPBI Group is venturing into Scientific NFT Marketplaces

https://pharmaceuticalintelligence.com/nft-redefined-format-of-ip-assets/

We plan to MINT as NFTs several of LPBI Group’s IP Asset Classes, such as

Curations among our +6,100 Journal articles – IP Asset Class I
eTOCs – Electronic Table of Contents of our 18 Books – IP Asset Class II
Gallery of +6200 Biological Images embedded in our Journal articles – IP Asset Class V
E-Proceedings of +100 Medical and Biotech Conferences we had covered in Real Time, 2013 – 2022 – IP Asset Class III
Tweet Collections of the latest 40 Medical and Biotech Conferences we had covered in Real Time, 2013 – 2022 – IP Asset Class III

Examples:

Tweet Collection of 2022 #EmTechDigital @MIT, March 29-30, 2022

https://pharmaceuticalintelligence.com/2022/04/02/tweet-collection-of-2022-emtechdigital-mit-march-29-30-2022/

Analytics for @AVIVA1950 Tweeting at #EmTechDigital

https://pharmaceuticalintelligence.com/2022/04/11/analytics-for-aviva1950-tweeting-at-emtechdigital/

Review our Testimonials

https://pharmaceuticalintelligence.com/praising-lpbi/

Our PAST is here

https://pharmaceuticalintelligence.com/home-website-front-page/

https://pharmaceuticalintelligence.com/2019-vista/

Our FUTURE is here

https://pharmaceuticalintelligence.com/vision/

https://pharmaceuticalintelligence.com/blockchain-transactions-network/

https://pharmaceuticalintelligence.com/synthetic-biology-in-drug-discovery/

https://pharmaceuticalintelligence.com/2021-medical-text-analysis-nlp/

https://pharmaceuticalintelligence.com/2021/07/24/proposal-for-new-e-book-architecture-combining-a-bi-lingual-etocs-english-spanish-with-nlps-results-of-medical-text-analysis-series-b-genomics-volume-1-2-and-series-c-cancer-volume-1/

Podcast of our Leaders are here

https://pharmaceuticalintelligence.com/audio-podcasts/

A stream of Ten INNOVATIONS in the Life of LPBI since

inception in 2012 to 2022

4/2012 – LPBI was the Launcher of a novel Scientific Curation Methodology for scientific findings in published primary research in the Global e-Scientific Publishing industry https://pharmaceuticalintelligence.com/
As late as 2016, no big publisher, not even one, i.e., Elsevier, John Wiley had curation-based publications: Journals, Books, e-Proceedings or Gallery of thousands of Biological Images as an IP asset class
At LPBI, Curation of scientific findings was performed in +6,000 articles with +2MM e-Views by Global e-Readers
6/2013 – LPBI was the Publisher of the 1^ste-book in Medicine in Kindle Store on the Life Sciences & Medicine Shelf – Upload to this shelf by Amazon.com
2/2021 – Completion of the 18 volumes, BioMed e-Series in five Specialties in Medicine: each article in each volume is a curation-based publication.
On Amazon.com on 7/2021 – LPBI’s e-books in Medicine enjoy +128,100 PAGE DOWNLOADS – the ONE and ONLY publisher in that range of page downloads. The record is the equivalent of 64 books at an average of 2,000 pages a volume !!!! LPBI smallest book is 1,000 pages and its biggest is +3,700 pages
LPBI launched its Natural Language Processing (NLP) Practice in 1/2020 as Mission #1. NLP is one method of Machine Learning (ML). ML is a family of methods in Artificial Intelligence (AI) which is a field in the Computer Science Academic discipline since the early 60s.
In 4/2021 Linguamatics/IQVIA performed NLP on LPBI’s 33 articles and 20 Biological Images. RESULTS: +670 entity relations DISCOVERED by Linguamatics and unknown to Pharma and to Insurers, entity relations between:

Gene-Disease
Gene-Drug
Disease-Drug

These results were jointly presented to a Healthcare Insurer, SLC, UT on 7/13/2021, forthcoming meeting in 9/2021.

LPBI and BurstIQ are architecting NOW the first Natural Language Processing – Blockchain Information Technology infrastructure in existence, This statement is TRUE.

Updated on 7/28/2021:Fluree Flur.ee, the Web3 Data Platform Open source semantic graph database & LeadSemantics.com presented their solution for NLP and Blockchain on 7/28/2021. Erich G. was lured as Chief architect for LPBI’s Mission #2: NLP & Blockchain
Linguamatics, the leader in NLP did not hear of Blockchain and BurstIQ did not have a request for NLP – LPBI PUT THESE TWO TECHNOLOGIES AND PARTIES TOGETHER

See IMAGES SOURCE: BurstIQ image for LPBI

https://pharmaceuticalintelligence.com/2021/03/02/2-0-lpbi-is-a-very-unique-organization/

On 7/19/2021 – LPBI had launched LPBI India for Synthetic Biology Software for Drug Discovery targeting Galectins – Collaboration with Dr. Raphael Nir, President and CSO, SBH Sciences, Inc., Natick, MA
On 7/25/2021 – LPBI announced that it will have the NEWLY to be published BioMed e-Books As Mission #3:
A NEW Publishing GENRE of SCIENTIFIC BOOKS

o Bi-Lingual electronic Table Of Contents (eTOCs), English & Spanish with Montero Language Services, Madrid as the Translator of eighteen Books’ Cover Pages and the 18 books electronic Table of Contents.

o The Content promotion in the Spanish speaking Countries with GTO, Madrid as AD Agency.

o NLPs results of Medical Text Analysis with domain knowledge expert Interpretations in Foreign Languages and in Audio: in Spanish and in other languages, forthcoming

o Original English Book – Only Editorials (Preface, Introductions, Summaries and Epilogue) because the Bi-Lingual part has the eTOCs of the e-Book

o This is a new genre and a new architecture of 18 MULTIMEDIA SCIENTIFIC e-Books with (a) NLP results of the Medical Text analysis with machine learning, (b) Expert Interpretation of the Visualization Results. Bi-Lingual Podcasts: (c) eTOCs and (d) Bi-Lingual Expert Interpretation in English and Spanish Text and audio Podcasts, and (e) Books’ Editorials in English Audio Podcast

Content promotion proposal by GTO, Madrid

See IMAGES SOURCE: Rendition by GTO, Madrid of BurstIQ Image, above

2.0 LPBI is a Very Unique Organization

9. The Content Monetization effort includes the Price List for LPBI 1.0 digital products and of LPBI 2.0 – NLP Products

Under development

IP Valuation Model per IP asset class is needed to be compared with Master_Financials and to supplement it
Pricing Model and Product Mix Models for the digital products to be generated by the process of Text Analysis with NLP are using a Product Price List already developed.
The scenarios for a Probabilistic Product Mix for the B2B sector are work-in-progress. Scenarios of Product Mix for $500,000 B2B engagements with NLP scaling up with NLP Alliances. The Alliances are the Labor component and LPBI represent Materials (Content) as 25% of the contract price, on top of total, to be paid by the B2B customer as materials in use for the engagement.
B2C Customers on Blockchain will use the Price List for all Digital Products of LPBI 1.0 and LPBI 2.0 – Pay per Use

10. LPBI Group runs FIVE ACADEMIC INTERNSHIPS as Certificate Programs: a One Year long or a One Semester long: Volunteer base offering Verifiable Certificates, as described in https://pharmaceuticalintelligence.com/certificate-1-year/

Read Full Post »

Analytics for @AVIVA1950 Tweeting at #EmTechDigital

Posted in Conference Coverage with Social Media, LPBI Group Founder - Aviva Lev-Ari, LPBI Group, e-Scientific Media, DFP, R&D-M3DP, R&D-Drug Discovery, US Patents: SOPs and Team Management, LPBI Management on April 11, 2022| Leave a Comment »

Analytics for @AVIVA1950 Tweeting at #EmTechDigital

Reporter and Curator: Aviva Lev-Ari, PhD, RN

Data SOURCE

https://analytics.twitter.com/user/aviva1950/tweets

TWEET HIGHLIGHTS

Top Tweet earned 122 impressions

#EmTechDigital@AVIVA1950@pharma_BI@techReview Prem Natarajan Vice President Alexa AI #explainability#analytics device and broadly decisions what stay on edge vs cloud #federated#learning#Healthcare physical obstacles to learn language less constrained Alexa5 more creative

1 2

View all Tweet activity

Top mention earned 7 engagements

#EmTechDigital@AVIVA1950@pharma_BI@techreview Agrim Gupta, Stanford Vision Learning Lab, Stanford University Baldwin Effect genotypic modification phynotypic behavior #dl GPT-OpenAI CLIP MetaMorph process transformer Encode Decode

1 1

Impressions

Engagements

Engagement rate

Aviva Lev-Ari @AVIVA1950
Aviva Lev-Ari @AVIVA1950 Apr 6#Analytics for #eReputation based on #LinkedIn 1st Degree #Connections, +7,500 of LPBI Group’s Founder, 2012-2022: An Intangible Asset – Connections’ Position Seniority & #Biotech / #Pharma Focus pharmaceuticalintelligence.com/2022/04/04/ana… via @pharma_BI @AVIVA1950

29

3

10.3%

Aviva Lev-Ari @AVIVA1950 Apr 4Analytics for e-Reputation based on LinkedIn 1st Degree Connections, +7,500 of LPBI Group’s Founder, 2012-2022: An Intangible Asset – Connections’ Position Seniority & Biotech / Pharma Focus pharmaceuticalintelligence.com/2022/04/04/ana…

5.6%

Aviva Lev-Ari @AVIVA1950 Apr 3Tweet Collection of 2022 EmTechDigital @MIT, March 29-30, 2022 pharmaceuticalintelligence.com/2022/04/02/twe…

12

0

0.0%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Apr 2Great achievement to content in PharmaceuticalIntelligence.com published by LPBI Group’s Team members @Pharma_BI @AVIVA1950 @StephenJWillia2 twitter.com/StephenJWillia…

27

0

0.0%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Apr 14 people followed me // automatically checked by fllwrs.com

21

2

9.5%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview FRONTIER OF #AI follow my tweets of this event more than few tweets per speaker

48

3

6.2%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview David Ferrucci Founder, CEO & Chief Scientist, Elemental Cognition technical side invent language models on business side extrapulate communicate better Watson strength and weakness

43

2

4.7%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview David Ferrucci Founder, CEO & Chief Scientist, Elemental Cognition project insights into understanding why Human need to understand internal models read understand dialog demand #ai to do that in dialog expert engages intelligently

46

3

6.5%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview David Ferrucci Founder, CEO & Chief Scientist, Elemental Cognition machine do not understand human reasoning is different bias inductions extrapulate decisions my machines are not trusted accountability understand why this decision

41

2

4.9%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview David Ferrucci Founder, CEO, & Chief Scientist, Elemental Cognition ex-IBM WATSON pre-Watson Jepordy expert system knowledge acquisition bottle neck did not think independently #ml #ontologies and #nlp machine did not understand

101

4

4.0%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Natasha Jaques Senior Scientist, Google Brain applications in robotics emerging behavior multi-agent environment adversary environment perturb by limits in OR imitation work #Inverse #RL extract personal utility function relevance

55

2

3.6%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Natasha Jaques Senior Scientist, Google Brain Application how to navigate the Web to book flights generated environment testing benchmarks more successful vs prior learning PAIRED approach best

52

2

3.8%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Natasha Jaques Senior Scientist, Google Brain Prior work with deep RL adversaries automatic curriculum generalized environment Agent learning emergent complexity domain randomization minimax adversarial paired App Web Navigation

39

2

5.1%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Natasha Jaques Senior Research Scientist, Google Brain social environment and complex behavior generalization and transfer deep RL domain randomization partial observability complex environments Adversarial environment generation

44

2

4.5%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Natasha Jaques Senior Research Scientist, Google Brain Reinforcement Learning #RL Ai Agent environment AlphaGo Zero 5 million games for training Robotics OpenAI generalization Social Learning learn from other intelligent agents

54

2

3.7%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Zenna Tavares Research Scientist, Columbia University; Co-Founder, Basis data driven prior vs truth or bias principles behind human reasoning innovations needed in building model explainability for free expensive models

41

2

4.9%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Zenna Tavares Research Scientist, Columbia University; Co-Founder, Basis ParametricInversion casual probabilistic programming MCMC approximately universal reasoning machines

57

5

8.8%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Zenna Tavares Research Scientist, Columbia University; Co-Founder, Basis universal reasoning building blocks reasoning algorithms knowledge representation probabilistic simulation models Bayesian Synthesis causal reactive Probabili

48

2

4.2%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Agrim Gupta, Stanford Vision Learning Lab, Stanford University generative design and DERL control complexity #DL system embodied ai robot design configure robot to do a task optimization hardware design drones

56

5

8.9%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Agrim Gupta, Stanford Vision Learning Lab, Stanford University Baldwin Effect genotypic modification phynotypic behavior #dl GPT-OpenAI CLIP MetaMorph process transformer Encode Decode

57

9

15.8%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Agrim Gupta, Stanford Vision Learning Lab, Stanford University DERL Inner Loop UNIMAL Design Space evolutionary environments Evolved morphologies flat terrain morphological intelligence task suite agility stability manipulability

37

2

5.4%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Agrim Gupta PhD Student, Stanford Vision Learning Lab, Stanford University Outer Loop generational evolution stead-state evolution DERL Distributed Asynchronous Evolution

45

2

4.4%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Agrim Gupta PhD Student, Stanford Vision Learning Lab, Stanford University endless forms #morphology and control #environmental complexity #evolution #disembodied #ai #embodied #agents #ai combinatorial space fitness evaluation

56

2

3.6%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview JSameena Shah J.P. Morgan AI R&D JP Morgan Chase #bias proactively code to over right bias

37

2

5.4%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview JSameena Shah J.P. Morgan AI R&D JP Morgan Chase money laundering data is a customer of #ai data access trading simulation client side experience find intent empowring employees legal language NLP fairness bias #ai give uplift

60

3

5.0%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview JSameena Shah Managing Director, J.P. Morgan AI Research, JP Morgan Chase Data discovery search task aware move away from general search point solution build new components data discovery on use cases problems key not solutions

38

2

5.3%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview JSameena Shah Managing Director, J.P. Morgan AI Research, JP Morgan Chasecapital connect investor space Recommendation on sparce biparties graph company space #ai recommend matches lift significant machine level of success by #ai

53

4

7.5%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview JSameena Shah Managing Director, J.P. Morgan AI Research, JP Morgan Chase #Social #Calculator #sentimentanalysis #risk #mitigation downstream application Twitter/Reddit find #influencers

26

0

0.0%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Nicol Turner Lee, Brookings Institution accountability needed in #ai community

32

1

3.1%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Nicol Turner Lee, Brookings Institution rating system self regulatory norms and assumptions for products policy prescriptions requiring disclosure transparency on credit scoring algorithms framework feedback on algorithms used

36

2

5.6%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Nicol Turner Lee, Brookings Institution quality of the data of over representation prison data minority representation data is the part of model needs change #reputation #risk facial recognition technology does not work minorities

48

3

6.2%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Nicol Turner Lee Director, Center for Technology Innovation, Brookings Institution #decision makers and #policy #socialimpact of #technology in 30 years not enough social #impact for #civilrights #votingrights #equity #technology

32

2

6.2%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Tara Chklovski Founder & CEO, Technovation software engineers jobs for girls for income potential #ai is a great choice for girls to lead and to mentor

39

3

7.7%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Tara Chklovski Founder & CEO, Technovation education sector to empower girl donors and partners bias against minorities and girls financial capability of girls in the future building resilient communities the Planet can thrive

34

2

5.9%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Tara Chklovski Founder & CEO, Technovation partnering wiht Google girls entrepreneurship 350,000 participants bring #ml to schools fake news elderly help longer term impact of program sustained impact better curriculum for youth

27

3

11.1%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Tara Chklovski Founder & CEO, Technovation competition for girls for sustainable development 900MM girls in the World educating girls STEM #ai agency purpose join a program work teams mentors physiologically thrilling competition

35

2

5.7%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Lauren Bennett Spatial Analysis and Data Science, Esri Clinton Johnson Racial Equity, Esri #GIS #maps and #geographies is the tool for #equity of #needs #disparities

42

2

4.8%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Lauren Bennett Spatial Analysis and Data Science, Esri Clinton Johnson Racial Equity, Esri air quality overall in US is improving except community of color Milwaukee, WI all parties work together

40

2

5.0%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Lauren Bennett Spatial Analysis and Data Science, Esri Clinton Johnson Racial Equity, Esri map the data ready for analysis missing data missing values outliers over prediction #representiveness of the models

35

1

2.9%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Lauren Bennett Spatial Analysis and Data Science, Esri Clinton Johnson Racial Equity, Esri #spatial-lens #equity-lens outcome #people race age gender equity process analysis conditions impact of the process data science role of #ai

37

2

5.4%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30Amazing event @MIT Follow my tweets #EmTechDigital @AVIVA1950 @pharma_BI @techreview twitter.com/Pharma_BI/stat…

21

0

0.0%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Tony Jebara VP Eng Head of ML, Spotify recommendation engines better than search personalization future more content magic connection

60

4

6.7%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Tony Jebara VP Eng Head of ML, Spotify large scale on audio Netflix on Video much bigger both management of content with #ai explicite data and implicit data listen one hour vs scroll down subscription fee long term reward & tools

153

3

2.0%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Tony Jebara VP Eng Head of ML, Spotify Reinforcement Learning #RL perception value function user state observations reward action simulators of users’ response to content before test on user #ml clicks to clicks #rl better data

47

3

6.4%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Tony Jebara VP Eng Head of ML, Spotify new Genre long term personalization not the most likely click but a journey familiar and new podcast and music value relationships with audio reinforcement learning

34

0

0.0%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Tony Jebara VP Eng Head of ML, Spotify personalized playlist – experience discover weekly release radar on repeat repeat rewind Algotorial (human experts) playlists Recommendation short term long term

58

5

8.6%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Tony Jebara VP Eng Head of ML, Spotify Data shared models audio analytics experience user affinity to music ai search page playlist assembling liking skipping ml to find album found attribution content understanding similar tracks

29

0

0.0%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Tony Jebara VP Eng Head of ML, Spotify unlock human creativity in audio listeners-audio recommendations & music creators-curations scale 200MM users, millions podcast titles, 4Bil music playlists music and podcast relations

40

2

5.0%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Darcy MacClaren Digital Supply Chain, SAP NA ai will become best of practice in 12 months Simhi-Levi volumes down recession is coming

25

0

0.0%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Darcy MacClaren Digital Supply Chain, SAP NA blockchain great technology secure transactions Simhi-Levi trusted partners vs changing fast blockchain critical trust partners explaining variability with ai

36

3

8.3%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Darcy MacClaren Digital Supply Chain, SAP NA CPG demand forecast use of ai in demand forecast and planning success by Dannon globally unified view of demand @MIT consumption data to predict order management with ai vs what sold

45

3

6.7%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Darcy MacClaren Digital Supply Chain, SAP NA flow offshoring cut cost 1/2020 pandemic in China in 3/2020 supply chain was predicted to stop SAP uses digital-twin supply chain Resiliency is a digital twin ai human areas automation

25

0

0.0%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Darcy MacClaren Digital Supply Chain, SAP NA David Simchi-Levi Director, Data Science Lab, MIT supply chain Resiliency mapping digitization segmentation smart planning execution logistics expensive loss flexibility demand planing

19

0

0.0%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Darcy MacClaren Digital Supply Chain, SAP NA ai in business data strategy married ai tech bus process solution ai factory framework data architecture workforce go to market reuse components

32

2

6.2%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Fiona Tan CTO, Wayfair visual search competitive advantage

19

0

0.0%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Fiona Tan CTO, Wayfair Geo-Sort proximity average logo miles search results relevance proximity optimize high quality substitute if product not found connect customers and suppliers #ml adoption interst using focus tech platform

49

3

6.1%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Fiona Tan CTO, Wayfair understand subjective language lexical search in catalog ML matching vs understanding consistent catalog product understanding (DNA) visual content easy finding red sofa dimensions quality prediction failure

25

0

0.0%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Fiona Tan CTO, Wayfair #ml #adoption and #risk #tolerance ml maturity lexical search recommendation online shopping investments mode semantic search customer intent first steps supply chain Geo-Sort

32

2

6.2%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Naveen Kamat Data AI Services Kyndryl model monitoring model extendability consume insight is critical service integrators innovate internally partner ecosystem protect existing investment in IT facing platform new deployment

50

3

6.0%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Naveen Kamat Data AI Services Kyndryl data privacy security expectation of availability and seamless management data consumption by business analysts executive concern disruption of business by changes to IT delays become liability

41

2

4.9%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Naveen Kamat Data AI Services, Kyndryl data fabric approach architecture for data discovery lego blocks integrate through APIs unified console performance across processing engines data operations predictable next transformation

42

2

4.8%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Naveen Kamat Data AI Services, Kyndryl, Bangalore democratizing ai data is dynamic schema drift data drift data governance curated feature stores data observability industrialized ai transfer learning AutoML MLOps synthetic data

53

2

3.8%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Mira Murati SVP OpenAI model optimise average behavior pre-training more advance tasks get harder training is done by @OpenAI talk to regulator share capabilities of the model with regulator collaboration cross industries

71

2

2.8%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Mira Murati SVP OpenAI scaling up using #ml techniques book summarization example Instruct GPT3 for misuse deploy model in API observe what users do post product control used behavior if misuse

41

1

2.4%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Mira Murati SVP OpenAI Alignment approach will generalize models get more capable human feedback judgement goog not good becomes training for the model with #ml techniques for supervised learning

48

3

6.2%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Mira Murati SVP OpenAI InstructGPT3 generates helpful outputs utility created for business DALL-E create chair in shape of avocado cat playing checker output of neural networks amazing

49

1

2.0%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Mira Murati SVP OpenAI GoogleMaps the decisions are taken by the program iterative approach gets Reinforcement learning from Human Feedback desirable non-desirable behavior

26

0

0.0%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Mira Murati SVP OpenAI GPT-3 to create business insights unstructured data analyzed from GitHub for application Copilot intervene at deployment stages fine tune model Filters in API documentation monitoring detection alignment

45

0

0.0%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Mira Murati SVP OpenAI GPT3 understand language Predicting the next word well for doing tasks CLIP predict description of an image DALL-E predict a word in an “image sentnece” Codex – predict word in context all modalities is goal

51

1

2.0%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Mira Murati SVP OpenAI develop #ai to benefit #Humanity human intent efficient Neural Networks biological network learning foundation of intelligence labelled dataset chat machine translation supervised learning

63

3

4.8%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Oriol Vinyals Principal Scientist, DeepMind CERN is Public AlphaCode is Private grant process can inspire

89

2

2.2%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Oriol Vinyals Principal Scientist, DeepMind competitive coding Alpha style Coding started 2018 using community of programmers #GitHub scaling up massive clusters expensive Attention become the Transformer model CERN teach AlphaCode

89

0

0.0%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Oriol Vinyals Principal Scientist, DeepMind Progresss since 4/2021 at 34% like Human defined AlphaCode’s estimated rating of NLP visualizing AlphaCode original vs Opposite change in meta data on results Alpha for Weather, Protein

76

0

0.0%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Oriol Vinyals Principal Scientist, DeepMind sample picking with clustering pick programs from different clusters data is key compute is key CodeContests CodeForces leave 15,000 samples picking randomly Clustering Evaluation

93

0

0.0%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Oriol Vinyals Principal Scientist, DeepMind Architecture seq2seq transformers encode problem definition decode problem solution Github data curated dataset for training by AlphaGo AlphaCode filtering code models supervised learning

87

1

1.1%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Oriol Vinyals Principal Scientist, DeepMind Human like problem solving by efficient code AlphaCode competitive programming algorithmic challenge to write a string input output formatting code runs and is correct AlphaGo AlphaFold

105

0

0.0%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Ali Alvi Turing Group PM, Microsoft training datasets disruptive experiences computers cheaper faster training models more parameters connections the neural network inference about subjective concepts is difficult responsible #ai

45

3

6.7%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Ali Alvi Turing Group PM, Microsoft future of Foundational models interactive #ai replace #ml with blocks of #DeepLearning Jeopardy unified multi-modality models doing tasks fusion language with images wordclouds is word image

34

1

2.9%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 30#EmTechDigital @AVIVA1950 @pharma_BI @techreview Ali Alvi Turing Group PM, Microsoft #dl #model Foundation model labeled data teacher model student model Prod model explosive growth in model size training compute FLOPs Turing NLG 530B Feature eng using #ml homogenization of arch

27

0

0.0%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 29#EmTechDigital @AVIVA1950 @pharma_BI @techReview Refik Anadol CEO, RAS Lab; Lecturer, UCLA art for public place human in 21 Century simulation of #emotions #dreams #memories #blockchain #quantum #ai @Google #contour #graphic #life-under-water #music using #ai #MOMA #archive #art

102

5

4.9%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 29#EmTechDigital @AVIVA1950 @pharma_BI @techReview Danny Lange SVP AI Unity Technologies #training data #humanoids #feedbackloop #sensors #IOT #ml data #controlmodel #digitaltwin #Sim-to-Real #simulateIntelligence #industrial #version #Analytics #tools #Bias #testing #verify models

17

0

0.0%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 29#EmTechDigital @AVIVA1950 @pharma_BI @techReview Danny Lange SVP AI Unity Technologies on #github repositories #videogames #synthetic data #generation #simulation #cognitive #visual #physical #social #training #ml systems #label #analytics of synthetic #dataset data drive models

9

0

0.0%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 29#EmTechDigital @AVIVA1950 @pharma_BI @techReview Mike Haley VP of Research, Autodesk #generative #ai #solution #space #iterative #design #fluid #simulation #valve evolving as a function of water pressure #jet #engine #site #mapping #designer #superpower #Components are redesigned

63

5

7.9%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 29#EmTechDigital @AVIVA1950 @pharma_BI @techReview Prem Natarajan Vice President Alexa AI #explainability #analytics device and broadly decisions what stay on edge vs cloud #federated #learning #Healthcare physical obstacles to learn language less constrained Alexa5 more creative

209

5

2.4%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 29#EmTechDigital @AVIVA1950 @pharma_BI @techReview Prem Natarajan Vice President Alexa AI #teachable ai #self-learning fits deploy at #edge data correction at the edge and #cloud #privacy edge devices interaction small # nodes #hardware #memory quantile new #chips #sustainability

98

1

1.0%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 29#EmTechDigital @AVIVA1950 @pharma_BI @techReview Prem Natarajan Vice President Alexa AI Head of NLU, Amazon 46MM Global users Edge vs Cloud #persistent #memory #inference #engine at the #edge update and learn at the edge #interaction no #latency #teachable #ai model update itself

90

0

0.0%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 29#EmTechDigital @AVIVA1950 @pharma_BI @techReview Sheldon Fernandez CEO, DarwinAI, preserving the fidelity of explainability algorithm monitoring for irregularities solar eclipse second order XAI is #metacognition #awareness of the XAI function #recommendation system in some XAI

24

0

0.0%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 29#EmTechDigital @AVIVA1950 @pharma_BI @techReview Sheldon Fernandez CEO, DarwinAI, Waterloo.edu ON, CA AI Explainability at the Edge in QA visual inspection quantitative explainability algorithm transparency sky purple turn left surface explainability to human uses ai

25

0

0.0%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 29#EmTechDigital @AVIVA1950 @pharma_BI @techReview Kavitha Prasad AI and Cloud Intel @nvidia #GPU @Intel #CPU #sharable data #ai-analytics platform companies Leaders in ai are #airbnb @Twitter @Netflix

12

0

0.0%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 29#EmTechDigital @AVIVA1950 @pharma_BI @techReview Kavitha Prasad AI and Cloud Intel @ai #transformation #deployment #edge #cloud deriving #outcomes ai model vs market monitoring of #ai #data is heterogenous exploding CPU to GPU #born-in-the-#Cloud #compute #security #context data

61

5

8.2%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 29#EmTechDigital @AVIVA1950 @pharma_BI @techReview Bali Raghavan, Engineering, Forward #Body #Model complex #camera calibration #pose depth frame build #proactive #HC system with #ai more #data bigger data is used in #synthesis improve success

39

0

0.0%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 29#EmTechDigital @AVIVA1950 @pharma_BI @techReview Bali Raghavan, Engineering, Forward 2017 SF anticipate #Health issues proactive HC system #ThermoCamera #bodyscanner #AmazonGo #OpenDoor #ai bridges #human #intelligence #Frameworks #sensor fusion #visualization #defects #learning

26

0

0.0%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 29#EmTechDigital @AVIVA1950 @pharma_BI @techReview Julia (Xing) Li Baidu USA Pre-training model #NLP #model #language generation #semantic #understanding in python #ai powered content #ecosystem search, feed, video platform speeding parameters #ai #creativity #writer #composers

35

2

5.7%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 29#EmTechDigital @AVIVA1950 @pharma_BI @techReview Julia (Xing) Li Baidu USA #Text-to-#Video @BaiduResearch #VidPress #process #writer #content #curator #media #producer #composer #editor technologies #nlp #video #image #search #multimedia #anchor alienment #recommendation #engine

118

2

1.7%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 29#EmTechDigital @AVIVA1950 @pharma_BI @techReview Andrew Moore Google Cloud AI, Google #staging #launch #optimize #calls satisfied without reaching representative #performance #tests risk #misuse #data Google supplies #platform #secure #cross #ai full #Solutions #Apprenticeship

18

0

0.0%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 29#EmTechDigital @AVIVA1950 @pharma_BI @techReview Andrew Moore Google Cloud AI, Google #ai is making #decision #system #prediction #traffic #mind #ml is training models Did #ml accuracy made #decisions better quality #ai achieved by prediction staged by #ml #models

11

0

0.0%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 29#EmTechDigital @AVIVA1950 @pharma_BI @techReview Joseph Lehar, Owkin #reverse #translation #precisionmedicine #oncology #Triple #negative #mentalhealth #patient-specific #treatment

23

0

0.0%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 29#EmTechDigital @AVIVA1950 @pharma_BI @techReview Haniyeh Mahmoudian Global AI Ethicist, DataRobot #ai reduce mitigate #bias #data #risk #ethics #trust #awareness #innovation with embedding #ethics risk #Reputation damage #Fairness #facial #recognition #usecase #representiveness

15

0

0.0%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 29#EmTechDigital @AVIVA1950 @pharma_BI @techReview #error in programmatic labeling use auto #ml aggregate #transactions

27

1

3.7%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 29#EmTechDigital @AVIVA1950 @pharma_BI @techReview RajivShah Snorkel AI #programmatic #labelling solution #heuristics converted #code #tagging integration of #labelled data #classification algorithms #scores #BERT improve ing quality of data labeling #functions #knowledge #graphs

25

0

0.0%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 29#EmTechDigital @AVIVA1950 @pharma_BI @techReview @AndrewYNg #NLP #customization of #tools data #standardization in #healthcare and trucking #datasystem #heterogeneity is highest #data life cycle of #ML

18

0

0.0%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 29#EmTechDigital @AVIVA1950 @pharma_BI @techReview @AndrewYNg in last decade #ML advanced #opencode frees effort to #dataset avoid #label inconsistency #images #small vs #big #data-centric #ai #system #dataset #slice #data #curation #teams develop #tools #storage #migration #Legacy

16

0

0.0%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 282022 EmTechDigital @MIT, March 29-30, 2022 pharmaceuticalintelligence.com/2022/03/28/202… via @pharma_BI Real Time Coverage: Aviva Lev-Ari, PhD, RN #EmTechDigital @AVIVA1950 @techReview

15

0

0.0%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 282022 EmTech Digital @MIT pharmaceuticalintelligence.com/2022/03/28/202… via @pharma_BI @AVIVA1950 #EmTechDigital

24

1

4.2%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 282022 EmTech Digital @MIT pharmaceuticalintelligence.com/2022/03/28/202…

14

2

14.3%

View Tweet activity
Aviva Lev-Ari @AVIVA1950 Mar 26#EmTech2022 @MIT twitter.com/StephenJWillia…

38

2

5.3%

Read Full Post »

Equity Sharing Calculation: A Scoring System for Author’s (a) Total Articles (single author) and (b) multiple authors (c) Total Articles Views (d) Author’s Proportion of own articles views in the Top 14 Journal articles by Views and (e) External Citations (f) Influencer on Twitter

Curators: Aviva Lev-Ari, PhD, RN and Stephen J. Williams, PhD

LPBI Group had developed a Scoring System for attribution of Equity Sharing in IP Asset Class I: Journal articles to Top Authors by number of articles published and by Views at all time for all articles published in the Journal

UPDATED on 12/30/2025

External Sources citing LPBI Group’s Authors by Citation Source, Type of Source and Number of Views of the Original Article
Author/Curator’s Name	Type of Citation	Views of Source Article, All Times, 12/2025	Referenced Article	Citation
Larry H. Bernstein, MD, FCAP	Presentation on Slideshare	17,908	Is the Warburg Effect the Cause or the Effect of Cancer: A 21st Century View? https://pharmaceuticalintelligence.com/2012/10/17/is-the-warburg-effect-the-cause-or-the-effect-of-cancer-a-21st-century-view/	Warburg Effect at https://www.slideshare.net/dsairamsairam/warburg-effect by Dr. Subhabrata Kar. Slide 5 “Comparison of Glycolysis between a Normal Tissue and Tumour/ Proliferated Tissue “
Larry H. Bernstein, MD, FCAP	Figure on web Presentation slideshow		figure used at https://pharmaceuticalintelligence.files.wordpress.com/2014/08/membrane_receptor_tk.jpg?w=500&h=326	Presentaion on EML4-ALK fusion gene Published with reusable license by Camille Kawawa-Beaudan at https://prezi.com/rbtv_450s3wd/eml4-alk-fusion-gene/
Larry H. Bernstein, MD, FCAP	figure		Figure used	Shashi Shekhar Anand, Navgeet, Balraj Singh Gill at https://www.pharmatutor.org/articles/breakthroughs-in-epigenetics
Larry H. Bernstein, MD, FCAP	journal article	43	Archives of Medicine (AOM) to Publish from “Leaders in Pharmaceutical Business Intelligence (LPBI)” Open Access On-Line Scientific Journal http://pharmaceuticalintelligence.com at https://pharmaceuticalintelligence.com/2015/07/01/archives-of-medicine-aom-to-publish-from-leaders-in-pharmaceutical-business-intelligence-lpbi-open-access-on-line-scientific-journal-httppharmaceuticalintelligence-com/	Bernstein, L.H. Archives of Medicine. Ca2+-Stimulated Exocytosis: The Role of Calmodulin and Protein Kinase C in Ca2+ Regulation of Hormone and Neurotransmitter. https://www.archivesofmedicine.com/medicine/ca2stimulated-exocytosis-the-role-of-calmodulin-and-protein-kinase-c-in-ca2-regulation-of-hormone-and-neurotransmitter.php?aid=7058
Larry H. Bernstein, MD, FCAP	company website	986	“Overview of Posttranslational Modification (PTM) \| Leaders in Pharmaceutical Business Intelligence (LPBI) Group.” Leaders in Pharmaceutical Business Intelligence (LPBI) Group, 29 July 2014, https://pharmaceuticalintelligence.com/2014/07/29/overview-of-posttranslational-modification-ptm/.	Post Translational Modification at https://www.beckman.com/resources/sample-type/bio-molecules/post-translational-modification
Stephen J. Williams, Ph.D	Peer Reviewed Academic Journal: Ing. Compet (2014) vol 16 No. 1	78	A Nonlinear Methodology to Explain Complexity of the Genome and Bioinformatic Information Available at https://pharmaceuticalintelligence.com/tag/fractal-geometry/	Pedro A. Moreno. Multifractal bioinformatics: A proposal to the nonlinear interpretation of genome. Ing. compet. vol.16 no.1 Cali Jan./June 2014. Print version ISSN 0123-3033
Stephen J. Williams, Ph.D	non peer reviewed preprint on Cold Spring Harbor preprint server biorxvix	461	Are CXCR4 Antagonists Making a Comeback in Cancer Chemotherapy?at https://pharmaceuticalintelligence.com/2015/12/15/are-cxc4-antagonists-making-a-comeback-in-cancer-chemotherapy/	Gokmen Altay, Elmar Nurmemmedov, Santosh Kesari, David E. Neal. Disease mechanism, drug-target and biomarker prediction software: Application on prostate cancer and validation bioRxiv 129742; doi: https://doi.org/10.1101/129742.previous version: Genome-wide differential gene network analysis R software and its application in LnCap prostate cancer. (2017). t doi: posted April 24, 2017. https://doi.org/10.1101/129742;
Stephen J. Williams, Ph.D	website post	2538	The SCID Pig: How Pigs are becoming a Great Alternate Model for Cancer at https://pharmaceuticalintelligence.com/2013/10/10/the-scid-pig-how-pigs-are-becoming-a-great-alternate-model-for-cancer-research/	website at https://www.minipiginfo.com/mini-pig-cancer.html
Aviva Lev-Ari, PhD, RN	Peer Reviewed Academic Journal: Chin J Cancer. 2012 Oct; 31(10): 463–470. Using 44.	1100	Lev-Ari A. Sunitinib brings Adult acute lymphoblastic leukemia (ALL) to Remission-RNA Sequencing-FLT3 Receptor Blockade. 2012. Available at: http://pharmaceuticalintelligence.com/2012/07/09/sunitinib-brings-adult-all-to-remission-rna-sequencing/	Yan-Fang Guan, Gai-Rui Li, Rong-Jiao Wang, Yu-Ting Yi, Ling Yang, Dan Jiang, Xiao-Ping Zhang, and Yin Peng. Application of next-generation sequencing in clinical oncology to advance personalized treatment of cancer. Chin J Cancer. 2012 Oct; 31(10): 463–470. Using 44.
Aviva Lev-Ari, PhD, RN	clinical trial reference	620	Ustekinumab New Drug Therapy for Cognitive Decline resulting from Neuroinflammatory Cytokine Signaling and Alzheimer’s Disease at https://pharmaceuticalintelligence.com/2013/02/27/ustekinumab-new-drug-therapy-for-cognitive-decline-resulting-from-neuroinflammatory-cytokine-signaling-and-alzheimers-disease/	Clinical Trial NCT02835716 Protocol “Pre-Clinical (Alzheimers) Diagnosis PCD = Optimum Outcomes OO (PCD=OOALZ)” by Millennium Magnetic Technologies, LLC
Tilda Barliya PhD	blog post	149	Cancer Metastasis at https://pharmaceuticalintelligence.com/2013/07/06/cancer-metastasis/	blog post at https://tginnovations.wordpress.com/2012/05/08/cancer/

UPDATED on 10/12/2022 for 4/10/2019

(f) Influencer ranking at World Medical Innovation Forum ARTIFICIAL INTELLIGENCE in MEDICINE

Top 3 Ranked by Betweenness Centrality in Top 10 Influencers #WMIF19 @phsinnovation @evankirstel @aviva1950 – Twitter Analytics by NodeXL http://bit.ly/2KB6cPN for #WMIF19 by

@PHSInnovation at World Medical Innovation Forum ARTIFICIAL INTELLIGENCE, Boston, MA USA, Monday, April 8-10, 2019

@symplur‘s #Healthcare Hashtags – Twitter Analytics published for http://bit.ly/WMIF19

[Top 10 by Mentions – @pharma_BI = 4 with 181 mentions]
[Top 10 by Tweets @AVIVA1950 = 2 with 229 Tweets (N = 152 Direct messages)]

www.worldmedicalinnovation.org

Recognition for LPBI Group’s IP Asset Class III: e-Proceedings and Tweet Collections

https://pharmaceuticalintelligence.com/2019/04/11/top-3-ranked-by-betweenness-centrality-in-top-10-influencers-wmif19-phsinnovation-evankirstel-aviva1950-tweeter-analytics-by-nodexl-http-bit-ly-2kb6cpn-for-wmif19-by-phs/

UPDATED on 5/24/2022

(e) External Citations

More details are found in

https://pharmaceuticalintelligence.com/2020/12/08/papers-citing-pharmaceuticalintelligence-com/

(a) Author’s Total Articles (single author)

(b) Author’s multiple authors articles

(c) Author’s Total Articles Views

(d) Author’s Proportion of own articles views in the Top 14 Journal articles by Views

(e) External Citations – See UPDATED on 5/24/2022, above

(f) Global Score across all the parameters

Read Full Post »

Analytics for e-Reputation based on LinkedIn 1st Degree Connections, +7,500 of LPBI Group’s Founder, 2012-2022: An Intangible Asset – Connections’ Position Seniority & Biotech / Pharma Focus

Author: Aviva Lev-Ari, PhD, RN, Founder of 1.0 LPBI, 2012-2020 & 2.0 LPBI, 2021-2025

and

Data Scientist, Research Assistant III: Tianzuo George Li

LPBI Group Logo

Picture date: 2/6/2022

Aviva Lev-Ari, PhD, RN

Founder of 1.0 LPBI, 2012-2020 & 2.0 LPBI, 2021-2025

BIOGRAPHY

We discussed the relations of e-Reputation as an Intangible Asset of the Firm in the following articles:

The Digital Age Gave Rise to New Definitions – New Benchmarks were born on the World Wide Web for the Intangible Asset of Firm’s Reputation: Pay a Premium for buying e-Reputation

Curator: Aviva Lev–Ari, PhD, RN

https://pharmaceuticalintelligence.com/2019/07/31/the-digital-age-gave-rise-to-new-definitions-new-benchmarks-were-born-on-the-world-wide-web-for-the-intangible-asset-of-firms-reputation-pay-a-premium-for-buying-e-reputation/

Curator: Aviva Lev-Ari, PhD, RN

Additional parameters of e-Reputation as an intangible asset for LPBI Group’s Founder and for LPBI Group as a Firm are analyzed in other articles, see the following List of Links:

Mostly HONORED to be followed by [from an Excerpt of 117 Followers of the Twitter Account @AVIVA1950 from the List of 359 Followers] by the Number of their Followers on 2/24/2019

LPBI Group is mostly HONORED to be followed by [from an Excerpt of 136 Followers of the Twitter Account @pharma_BI from the List of 505 Followers] by the Number of their Followers on 3/20/2019

Comparative Analysis of the Level of Engagement for Four Twitter Accounts: @KDNuggets (Big Data) @GilPress @Forbes @pharma_BI @AVIVA1950

Excerpt of 136 Followers of @pharma_BI (from the List of 505 Followers) by the Number of their Followers on 3/20/2019

Excerpt of 117 Followers of @AVIVA1950 (from the List of 359 Followers) by the Number of their Followers

REACH – Two Handles on Twitter.com @AVIVA1950 @pharma_BI

Connections First Level on LinkedIn: 500 CEOs, 200 Big Pharma Professionals, 7,000 in Total: LPBI Group Founder – Aviva Lev-Ari, PhD, RN

For @AVIVA1950, Founder, LPBI Group @pharma_BI: Twitter Analytics [Engagement Rate, Link Clicks, Retweets, Likes, Replies] & Tweet Highlights [Tweets, Impressions, Profile Visits, Mentions, New Followers] https://analytics.twitter.com/user/AVIVA1950/tweets

The Digital Age Gave Rise to New Definitions – New Benchmarks were born on the World Wide Web for the Intangible Asset of Firm’s Reputation: Pay a Premium for buying e-Reputation

Institutional versus Personal: Statistical Analysis of Two Twitter Handles – @pharma_BI (LPBI Group’s Official) and @AVIVA1950 (LPBI Group’s Founder’s Personal) – Comparative Analysis of Followers and The Followers of these two Handles’ Followers

UPDATED on 5/9/2022

Based on 2/13/2022 data download

LPBI Group’s Founder’s 1st Degree Connections on LinkedIn by

Sector Type and by Number of Connections in each Sector

Sector Type	Number of Connections
Big Pharma	130
University	99
Academic Medical Center	53
CRO	46
Biotech	35
Cloud Computing	29
Genomics	24
Medical School	22
Medical Devices	18
Medical Equipment	18
Academic Medical Center – Israel	17
Big Pharma – Israel	15
Big Pharma – Japan	15
BioSciences	15
Cloud IT	15
Medical Research Institute	15
Institute of Technology	11
Biological Sciences Research Institute Israel	10
Healthcare Insurance	10
Scientific Publisher	10
Biotech – Immunotherapy	9
Biotech – Israel	9
Government Agency – Drug Administration	8
Healthcare Insurance Company	8
HMO	8
Big Pharma – France	7
Institute of Technology – Israel	7
Medical Professional Association	7
Research Institute	7
HMO – Israel	6
Large Biotech	6
Media	6
Top Four Accounting	6
University – UK	6
Big Four Accounting	5
BioInstrumentation – Genomics	5
Medical Center	5
Technology Transfer Office – Israel	5
VC	5
Business/diplomacy – Israel	4
Federal Agency	4
Medical Research Institute/Foundation	4
University – Canada	4
Government Office – Israel	3
Top Tier Management Consultinf on IT	3
Top Tier Management Consulting	3
Univeristy – Israel	3
World Largest Thinktank	3
Big Pharma – Swiss	2
Big Pharma – US	2
BioMed Research Institute, ME Independent non-profit	2
BioTech PharmacoGenomics	2
Community Hospital	2
Government funded Basic Research	2
Government funded R&D	2
Government funded R&D – Israel	2
Management Consulting	2
Medical Center – Israel	2
Medical Devices – Israel	2
Medical Office	2
Medical Professional Accociation – Israel	2
Pharma – India	2
Professional Association	2
Professional Medical Society	2
Research Institute – Israel	2
Research Institute on Hightech – Israel	2
Top Four Accounting – Israel	2
Top Tier Management Counsulting – India	2
University – Australia	2
University – Israel	2
VC – Israel	2
3D Bioprinting – Dental	1
Academic Medical Center – Canada	1
Academic Medical Center – Spain	1
Academic Medical Center – Sweden	1
Academic Medical Center- Israel	1
Academic Medical School	1
AI	1
Big Pharma – Europe	1
Big Pharma – Poland	1
BioMed	1
BioMed AI	1
Biotech – Immunotherapy – Germany	1
Biotech & Gne Medicine – USA & Canada	1
Biotech Consorsium	1
Business – Israel	1
Business Association NE & Israel	1
Community Medical Center	1
Economic Research Institute	1
Governement funded Research	1
Government Ministry of Health – Israel	1
Government Office – China	1
Government Office -Taiwan	1
Government Research Center	1
Healthcare R&D – India	1
HMO & Healthcare Insurance	1
Institute of Technology – India	1
LAB	1
Law Firm	1
Library – Israel	1
Life Science Institute – Japan	1
Medical Center – Canada	1
Medical Center – India	1
Medical Center (VA)	1
Medical Clinic	1
Medical Equipment – Israel	1
Medical Institute/Foundation	1
Medical Professional Society	1
Medical Research Center	1
Medical Research Institute – Academic Medical Center	1
Medical Research Institute – Canada	1
Medical Research Institute (VA)	1
Medical School – Brazil	1
Medical School – Bulgaria	1
Medical School – Canada	1
Medical School – Iran	1
Medical School – Spain	1
Medical School – Thailand	1
Medical Technology & Equipment	1
NGO – Healthcare	1
Pathology – AI	1
Pathology – AI – Israel	1
Pharma – France	1
Pharma manufacturer – Ireland	1
Pharma R&D – Not by Pharma	1
Pharmaceutical & Biotech MEDIA	1
Pharmaceutics – Switzerland	1
Professional Accociation – Denmark	1
Professional Medical Association	1
Research Center Independent Non-profit	1
Research Institute – Indonesia	1
Research Institute (Private) – Brazil	1
Research Institute at Academic Mmedical Center – Israel	1
Research Institute/Foundation	1
Scientific Publisher – Sweden	1
Top Four Accounting – South East Asia	1
Top Tier Medical Consulting	1
Univeristy – Israel – AFTAU	1
University – Latvia	1
University – Oman	1
University – Romania	1
University – Denmark	1
University – Finland	1
University – Germany	1
University – Greece	1
University – Italy	1
University – Porto Rico	1
University Health Services	1
VC – High Tech & Healthcare – Israel	1
VC – Hightech and Biotech	1
VC Biotech	1
VC Medical Devices & Pharma – Israel	1

The presentation of this one parameter focus on two dimensions:

Dimension #1: The Position Seniority of the Connections, and
Dimension #2: The industry concentration in Biotech / Pharma

Summary and Conclusions:

Founder’s LinkedIn 1st Degree Connections, N = +7,500

The industries represented by multiple 1st Degree Connections of LPBI Group’s Founder are the following:

Biotech & Pharma: Teva Pharmaceuticals, Novartis, AstraZeneca, J&J, Philips, ICON plc, IQVIA, Syneos Health, Takeda
HighTech IT & Internet: Amazon, Microsoft, Google
Academia: Weizmann Institute, Harvard Medical School
Others in 2022: Self employed, Home, Freelance

Marquee Corporations:

Their Leaders are 1st Degree Connections of LPBI Group’s Founder

Corporate Leaders are 1st Degree Connections of LPBI Group’s Founder

30% of the Total of 7,485 1st Degree Connections are +1,000 Directors, +700 CEOs, +400 VPs
+200 positions are of the company Presidents (2.25%)

Position of Interest Frequency Summary (include overlaps)
Position Name	Frequency (%)
CEO	736 (9.8%)
VP	412 (5.5%)
Director	1,010 (13.5%)

Industry Focus of the Marquee Corporations who’s Leaders are

1st Degree Connections to LPBI Group’s Founder

Summary of 3 Most Common Positions in Companies with 9 or More Connections
Company Name	Number of contacts	1st position	1st position count	2nd position	2nd position count	3rd position	3rd position count
Novartis	16	Manager	3	Lead	3	Director	2
Teva Pharmaceuticals	16	Senior Director	3	R&D Director & Manager	3	Senior Managers (other)	2
Amazon	15	Senior Program Manager	2	associate	2	Marketing & Sales Leader	2
AstraZeneca	14	Senior Director	2	Talent acquisition	2	Vice President	2
Johnson & Johnson	13	Vice President	3	Scientist	3	Director	3
Weizmann Institute of Science	13	Head, Leader, & Director	4	Scientist	3	Researcher	2
Philips	12	Head	2	Leader	2	Architect & Engineer	2
ICON plc	11	Recruiter & Recruitment Consultant	4	Directors	2	Manager of Clinical Operations	2
IQVIA	11	Director	3	Specialist	2	Consultant	2
Syneos Health	11	Director	3	Oncology Sales Representative	2	Clinical Research	2
Harvard Medical School	10	Professor	3	Instructor	2	Fellow	2
Mircrosoft	10	Engineer & Architect	3	Manager	2	Recruiter	2
Takeda	10	Head & Lead	4	Manager	3	Associate Director	2
Google	9	Manager	3	Engineer	2	Scientist & Researcher	2
Self-Employed	127	Consultant	24	Writer & Editor	10	Manager & Managing Director	8
Freelance	24	Consultant	7	Writer & Editor	6	Programmer	2

In Highest Frequency of Leading Positions we find the C-Suite

Of Note: Seniority of the Connections’ Positions – Managers, Directors, CEOs, Founders, Vice Presidents

Of Note: Managers, Directors, CEOs, Founders and VPs

Of Note: Managers, Directors, CEOs, Founders and VPs: Ease of Approachability in decrease order: Most accessible are Director level followed by VP level and least approachable are the CEOs in the corner offices.

Of Note: CFOs, Coordinators, Chairman/Vice Chairman, Experts, Business Owners, Researchers, Medical, Editors, others.

The Data was extracted on 2/13/2022 from LinkedIn Cloud.

First Degree LinkedIn Connections of Aviva Lev-Ari, PhD, RN Frequency Summary
The Positions of All Connections Frequency Summary (overlaps counted once)
Positions	Frequency
Total	7,485
Manager (other)	787
Director	733
CEO	718
Founder	449
ZZ_ other statistically insignificant positions	433
Vice President	360
Consultant	298
President	196
Specialist	160
Professor	148
Scientist	144
recruiter	138
Advisor	131
Business/Organization Owner	123
Co-Founder	120
Head	116
Managing Director	104
Engineer	86
Analyst	85
Managing Partner	76
Partner (other)	71
Principal	68
Retired	67
Writer	64
(Board) Member	62
Admin	53
Talent Acquisition	52
Account Manager	51
Officer	51
Chief Financial Officer	48
Coordinator	47
(Vice) Chairman	47
Associate	46
Assistant	45
Leader	42
Coach	39
Researcher	39
Account Executive	35
Expert	33
Business Development	33
Senior position (other)	33
Research Related (other)	30
Executive (other)	30
Strategy related (other)	28
Medical (other)	27
Attorney	26
Representative	26
Accounting (other)	24
Developer	24
Editor	24
Designer	23
Faculty	22
Supervisor	22
Principal Consultant	22
Lecturer	22
Agent	22
Intern	22
Sales Related (other)	22
Architect	20
Strategist (other)	19
Chief Operating Officer	19
Teacher	17
Technician	17
Actor	16
Instructor	15
Student	15
Nurse	15
Chemist	14
Mentor	14
Author	14
Investigator	13
Marketing (other)	13
Sales Executive	12
Chief Scientific Officer	11
Broker	11
Cardiologist	11
Chief (other)	11
Venture Partner	10
Postdoctoral Fellow	10

Read Full Post »

NCCN Shares Latest Expert Recommendations for Prostate Cancer in Spanish and Portuguese

Posted in Cancer - General, Cancer and Current Therapeutics, Cancer Informatics, Childhood cancer, Clinical & Translational, Curation, Global Medical Publishers by Country, Health Care System by Country, LPBI Management, Personal Health Applications: Tech Innovations serves HealhCare, Pharmaceutical Industry Competitive Intelligence, Pharmacovigilance, Population Health Management, Prostate Cancer: Monitoring vs Treatment, Scientific Publishing, tagged Brazil, breast cancer, Cancer, cancer treatment, Clinical decision support system, clinical trial guidelines, colon cancer, FDA, FDA guidance, Latin America, LPBI, Medical guideline, medical text, national cancer institute, National Comprehensive Cancer Network, NCCN, Regulatory, Spanish, translation, treatment decisions, treatment guidance on September 14, 2021| Leave a Comment »

NCCN Shares Latest Expert Recommendations for Prostate Cancer in Spanish and Portuguese

Reporter: Stephen J. Williams, Ph.D.

Currently many biomedical texts and US government agency guidelines are only offered in English or only offered in different languages upon request. However Spanish is spoken in a majority of countries worldwide and medical text in that language would serve as an under-served need. In addition, Portuguese is the main language in the largest country in South America, Brazil.

The LPBI Group and others have noticed this need for medical translation to other languages. Currently LPBI Group is translating their medical e-book offerings into Spanish (for more details see https://pharmaceuticalintelligence.com/vision/)

Below is an article on The National Comprehensive Cancer Network’s decision to offer their cancer treatment guidelines in Spanish and Portuguese.

Source: https://www.nccn.org/home/news/newsdetails?NewsId=2871

PLYMOUTH MEETING, PA [8 September, 2021] — The National Comprehensive Cancer Network^® (NCCN^®)—a nonprofit alliance of leading cancer centers in the United States—announces recently-updated versions of evidence- and expert consensus-based guidelines for treating prostate cancer, translated into Spanish and Portuguese. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines^®) feature frequently updated cancer treatment recommendations from multidisciplinary panels of experts across NCCN Member Institutions. Independent studies have repeatedly found that following these recommendations correlates with better outcomes and longer survival.

“Everyone with prostate cancer should have access to care that is based on current and reliable evidence,” said Robert W. Carlson, MD, Chief Executive Officer, NCCN. “These updated translations—along with all of our other translated and adapted resources—help us to define and advance high-quality, high-value, patient-centered cancer care globally, so patients everywhere can live better lives.”

Prostate cancer is the second most commonly occurring cancer in men, impacting more than a million people worldwide every year.[1] In 2020, the NCCN Guidelines^® for Prostate Cancer were downloaded more than 200,000 times by people outside of the United States. Approximately 47 percent of registered users for NCCN.org are located outside the U.S., with Brazil, Spain, and Mexico among the top ten countries represented.

“NCCN Guidelines are incredibly helpful resources in the work we do to ensure cancer care across Latin America meets the highest standards,” said Diogo Bastos, MD, and Andrey Soares, MD, Chair and Scientific Director of the Genitourinary Group of The Latin American Cooperative Oncology Group (LACOG). The organization has worked with NCCN in the past to develop Latin American editions of the NCCN Guidelines for Breast Cancer, Colon Cancer, Non-Small Cell Lung Cancer, Prostate Cancer, Multiple Myeloma, and Rectal Cancer, and co-hosted a webinar on “Management of Prostate Cancer for Latin America” earlier this year. “We appreciate all of NCCN’s efforts to make sure these gold-standard recommendations are accessible to non-English speakers and applicable for varying circumstances.”

NCCN also publishes NCCN Guidelines for Patients^®, containing the same treatment information in non-medical terms, intended for patients and caregivers. The NCCN Guidelines for Patients: Prostate Cancer were found to be among the most trustworthy sources of information online according to a recent international study. These patient guidelines have been divided into two books, covering early and advanced prostate cancer; both have been translated into Spanish and Portuguese as well.

NCCN collaborates with organizations across the globe on resources based on the NCCN Guidelines that account for local accessibility, consideration of metabolic differences in populations, and regional regulatory variation. They can be downloaded free-of-charge for non-commercial use at NCCN.org/global or via the Virtual Library of NCCN Guidelines App. Learn more and join the conversation with the hashtag #NCCNGlobal.

[1] Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global Cancer Statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, in press. The online GLOBOCAN 2018 database is accessible at http://gco.iarc.fr/, as part of IARC’s Global Cancer Observatory.

About the National Comprehensive Cancer Network

The National Comprehensive Cancer Network^® (NCCN^®) is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, efficient, and accessible cancer care so patients can live better lives. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines^®) provide transparent, evidence-based, expert consensus recommendations for cancer treatment, prevention, and supportive services; they are the recognized standard for clinical direction and policy in cancer management and the most thorough and frequently-updated clinical practice guidelines available in any area of medicine. The NCCN Guidelines for Patients^® provide expert cancer treatment information to inform and empower patients and caregivers, through support from the NCCN Foundation^®. NCCN also advances continuing education, global initiatives, policy, and research collaboration and publication in oncology. Visit NCCN.org for more information and follow NCCN on Facebook @NCCNorg, Instagram @NCCNorg, and Twitter @NCCN.

Please see LPBI Group’s efforts in medical text translation and Natural Language Processing of Medical Text at

2.0 LPBI – 2021-2025 VISION

2021-2025 Medical Text Analysis (NLP)

Read Full Post »

Standard Operating Procedures for Updating the Map of LPBI India

Posted in LPBI Management, tagged Google Slides, India, LPBI India, Maps, ZeeMaps on August 24, 2021| Leave a Comment »

Standard Operating Procedures for Updating the Map of LPBI India

Author: Srinivas Sriram

Co-Author: Abhisar Anand

To update the map of LPBI India, there are two major steps that are involved that use two different softwares. The softwares are:

Zee Maps (For actually Creating the Map with Landmarks)
Google Slides (For processing the map and making it look nice and downloadable as JPG).

This SOP Article will delve into how to update the map of LPBI India that is currently created on these softwares in the case that the map needs to be updated for new members of LPBI India or members who leave LPBI India.

Go to https://www.zeemaps.com/
Click on the “Sign In” button on the Top Right Corner:

Sign in to Zee Maps with the following credentials:
1. Email: lpbimap@gmail.com
2. Password: (Get the Password from Dr. Lev-Ari)
Once you are signed in, Click on the “MyMaps” page:
Click on “LPBI India Map” to edit the Map:

Now, you are in the Map. To see all the current landmarks of LPBI India Members, Click on the Side Bar at the very right of the page.

Now, you can see all the current members of LPBI India who are on the Map.
To add a new person to the map, do the following:
1. Click on the “Additions” section in the menu on the Left Side of the Page.
2. Click on “Add Marker – Simple”.
3. For Entry Name, Give the Name of the Person whom you are trying to add to the Map.
4. For Location, provide the Location of the Person whom you are trying to add (Just give the City Name and the Map should auto-complete a suggestion that is the correct location).
5. Then, you can click “Preview” to see how the new addition would look on the map, “Reset” to reset your changes, or “Close” to close the entry without saving it. If you are happy with the Entry, you can add the marker by clicking the “Submit” button at the bottom of the entry.
6. You have now added someone to the map, and you can see them on the table to the right.

To delete a person from the map, do the following:
1. Click the person you would like to delete on the map, and then click the trash can button (as shown in the screenshot).
2. Now, you have successfully removed someone from the Map, and they will no longer be visible on the table to the right.
Once you have updated the map per your liking, you now have to move on to the next step of the process.
1. First, take a screenshot of the updated map region similar to the example shown below and save it to your local computer.

You now need to access the Google Slide Document that makes the Map look better. Click on the link below to access the current LPBI India Map.
1. https://docs.google.com/presentation/d/1Jszv7_v7_ObjCHdSRIeygr6U9EZ0AwF_8Ud1Mh9R33o/edit?usp=sharing
This Google Slide has:
1. A screenshot of the Zee Maps Map with text boxes to make the numbers easier to read.
2. A table (the same as the table seen on the Zee Maps Screen) that contains the name of the LPBI India Member and the number on the map that corresponds with that LPBI India Member.
Insert your new screenshot of the Map you just took into the Google Slide Document, and then change the table on the right to make sure that it matches the table shown on Zee Maps. Make sure that for the map, the text boxes that make the numbers look larger match up the locations of the individual people on the map.
Edge Case: If two people have the same location, you cannot see both of the markers at the same location. This is why in the current map, numbers 3 and 6 and numbers 7 and 9 are on the same marker. Make sure that all the numbers match up and put the multiple numbers on the map if necessary.
Once you are satisfied with the updated LPBI India Map, you can download the Map in a variety of formats. Follow the instructions below to download the Map in the format that suits your needs.
1. On the top left corner, click on “File” (as shown in the screenshot)
2. Click on “Download”. A variety of formats show up. Click on the format that suits your needs (ex. .jpg, .png, .pptx, etc.). Then, the map should download on your local machine.
Now, you have successfully updated the map of LPBI India and downloaded it on your local machine! Send the updated map to Dr. Lev-Ari (if someone else is performing the map updates), and this can be used for LPBI India!

Read Full Post »

Standard Operating Procedures for Text to Audio Conversion – How to Create a Podcast and Embed it on a Post or on a Page

Posted in LPBI Management, Uncategorized, tagged Standard Operating Procedure on July 14, 2021| Leave a Comment »

Standard Operating Procedures for Text to Audio Conversion – How to create a Podcast and Embed it on a Post or on a Page

Author: Ethan Coomber, Research Assistant III, Data Science and Podcast Library Development

Ethan Coomber, Research Assistant III, Data Science and Podcast Library Development

https://pharmaceuticalintelligence.com/contributors-biographies/research-assistants/ethan-coomber-research-assistant-iii-data-science-and-podcast-library-development/

Most recent update: 7-12-21

*As of the writing of these steps, the Anchor feature that converts articles to podcasts is relatively new. As of my most recent communication with representatives of Anchor, they are planning on adding features that would simplify this process.

Converting an Article to a Podcast

The first thing you will need to do is create an account on Anchor who has recently partnered with WordPress to allow users to link their accounts and convert articles into podcasts. The link to do so is below.
- https://anchor.fm/wordpressdotcom
  - It is important to note that Anchor will not let you link to a WordPress account if you create a generic account it must be an account linked with WordPress. This link should allow you to do so.
Once you have linked your account, you will want to go to the tab for “Episodes”.

On the episodes tab, there should be a button that allows you to import articles from your WordPress account.
Unfortunately, as of this update, Anchor does not have a feature to allow users to search for a specific article. I have spoken with workers from Anchor who have told me they will work on implementing this feature right away so check and see if they have finished implementing a search bar or some other way to filter. As of this update, the articles are loaded in chronologically with the most recent articles appearing on the first page.
- If you are looking to convert an article that was recently published on WordPress, it should appear on this page or one of the first few.
- One option you have to try to find specific articles is to use the (command F) feature of a mac or the (control F) feature of windows. This allows you to search for a specific keyword within a page.
  - With the publishing date of the article you are looking for in mind, you should be able to find the article within a few minutes. Articles that were published earlier will take longer to find than articles published in the last couple weeks. Many of the articles have dates in their titles so as you go through the pages, you will be able to tell if you have passed your articles if the dates in the titles are from before when the one you are looking for was published. Similarly, you will know you have not arrived yet if the titles are from dates after the one you are looking for.
  - Each time you go to a new page, you will need to press the (command F) function, and then the (return) with the title (or a keyword or phrase from the title you are looking for) in the search bar. This will quickly search the page and tell you if the title you are looking for is there. If no results are found, you know you can go to the next one.
    - I have found this speeds up the process as I get in a rhythm of pressing the button for the next page and then quickly searching the page I am on.
    - If you do not press (command F) function, and then the (return), the search tool will not update and tell you if the word you are looking for is in the page.
    - You may want to play around with these features with an article on the first page or two to make sure you understand before searching for an article published several years ago.

Once you have found the article you are looking for, you will then press the large create episode button.

You will then be presented with the option to “Automatically convert to audio” or “Record” yourself.
If you would like to quickly automatically convert the article, select that option.

There are several voices you will then be able to select from. You choose the one you like most.

Anchor then converts the entire article.
- As of now there is no way to select only a portion of the text to convert so the entire article (including headers and captions) will be converted.
Once the article is converted, you will then press the “Save and continue” button.

Several optional features will then pop up. If you would like to add a song or messages to your podcast, this is the place where you would do it. Once the podcast is how you would like it, you then press the “Save changes” button.

If you would like to update the episodes “Cover art”. Select the pencil to the right of the podcast.

Scroll to the bottom and upload whatever image you would like.

Embedding a Podcast into an article

Once you have published an article on Anchor, you are now able to embed it within your article for viewers to listen and read at the same time.
When on Anchor, make sure you are on the Dashboard. There, you should see a button that says “View public site”. Click this button.

You will then be directed to a page that gives several options. You will then press the button that says “Listen on Spotify”

This will then take you to a page on Spotify instead of Anchor. Here, you will see all articles published using your anchor account. It may take a couple minutes for recently converted articles to show up on this page.
Once you see your podcast title, when you hover your mouse over the podcast, a box with an arrow pointing upwards will appear in the bottom right of your highlighted podcast. When you click this button, it will copy a link to your podcast on Spotify. You will use this link to embed your podcast.

Returning back to your WordPress article, insert a block where you would like your podcast to be embedded. When you press the plus button to insert a block, choose the browse all option. Scroll all the way down to embeds and select the one with the Spotify icon.

You will then be able to past the link you previously copied from Spotify, and your podcast will now be embedded.

Editing a previously published podcast

Anchor stores all previously published podcasts in the Episodes tab.
Once you are in Episodes, select the button in the bottom right that says “Last”. This will take you to where all published podcasts are.

If you would like to edit a podcast, click the three dots to the right of the podcast and select “View episode details”

This is where you can edit and save your podcast.

Read Full Post »

Standard Operating Procedures for creating a DropBox Account

Posted in LPBI Management, tagged Dropbox, Dropbox Registration, LPBI Dropbox Folder, Procedure on July 14, 2021| Leave a Comment »

Standard Operating Procedures for creating a DropBox Account

Author: Abhisar Anand
Co-Author: Srinivas Sriram

Please follow these steps in order to register for a DropBox Account

1. Go to https://www.dropbox.com/login

2. Click on the option “create an account”

3. Fill in the corresponding information (First name, Last name, Email, Password, Check the terms box).

4. Click the “Create an account” button.

5. Click on the “Or continue with 2 GB Dropbox Basic plan” option.

6. Go to https://www.dropbox.com/ (login if needed)

7. Email Dr. Lev-Ari regarding requiring access to the LPBI folder with the email you registered within the body of the email.

Read Full Post »

UPDATED to 1/1/2023 –>> February 1, 2021 – We Celebrate 1,924,400 e-Readers, 6,000 Scientific Journal Articles, 7,525 Scientific Comments, A Journal Ontology of 728 Medical & Life Sciences Research Categories, 10,440 Tags, Top Article 17,300 Views, Top Author 487,500 Views on PharmaceuticalIntelligence.com

Posted in LPBI Group, e-Scientific Media, DFP, R&D-M3DP, R&D-Drug Discovery, US Patents: SOPs and Team Management, LPBI Management on February 1, 2021| Leave a Comment »

UPDATED to 1/1/2023 –>> February 1, 2021 – We Celebrate 1,924,400 e-Readers, 6,000 Scientific Journal Articles, 7,525 Scientific Comments, A Journal Ontology of 728 Medical & Life Sciences Research Categories, 10,440 Tags, Top Article 17,300 Views, Top Author 487,500 Views on PharmaceuticalIntelligence.com

Reporter: Aviva Lev-Ari, PhD, RN

Update on 1/1/2023 by Srinivas Sriram and Abhisar Anand

1/1/2023- 2,205,188 views

Content

1/1/2023- 6,162 Posts

754 Categories

10,688 Tags

Internet Exposure Indicator (IEI) Table

Note: To calculate % change, we used the formula: % Change = (Newer – Older)/Older * 100%
All calculations were rounded to the nearest 0.01%.

INTERNET EXPOSURE INDICATORS (IEI)	% change 2/3/2022-1/1/2023	On 1/1/2023	% change 2/1/2021-2/3/2022	On 2/3/2022	% change 2/1/2021-7/1/2021	On 2/1/2021	On 7/1/2021
Total # of Journal Article Views	5.52% increase	2,205,188	8.59% increase	2,089,759	4.10% increase	1,924,462	2,003,415
# Categories	1.48% increase	754	2.06% increase	743	1.10% increase	728	736
# Tags	0.33% increase	10,688	2.03% increase	10,653	1.00% increase	10,441	10,545
TOP AUTHORS VIEWS
Aviva Lev-Ari	5.46% increase	536,209	9.73% increase	508,457	5.04% increase	463,371	486,733
Larry H Bern	7.46% increase	401,503	9.22% increase	373,618	4.30% increase	342,084	356,793
S J Williams PA	6.93% increase	77,537	8.55% increase	72,513	2.69% increase	66,800	68,594
Tilda Barliya	4.03% increase	72,751	5.64% increase	69,934	2.85% increase	66,203	68,093
Dr. Sudipta Saha	8.19% increase	42,291	6.23% increase	39,088	2.36% increase	36,797	37,665
Dror Nir	2.67% incease	39,337	6.84% incease	38,314	4.75% increase	35,862	37,564
Demet Sag Ph.D. CRA GCP	3.32% increase	20,694	5.10% increase	20,030	2.79% increase	19,058	19,590
Ritu Saxena	1.39% increase	17,571	1.90% increase	17,330	0.96% increase	17,007	17,170
Gail S Thornton	10.57% increase	20,027	15.63% increase	18,112	7.05% increase	15,664	16,768
Irina Robu	2.81% increase	10,495	13.18% increase	10,208	9.34% increase	9,019

Comparison of Internet Exposure Indicators (IEI’s) With Bar Graphs

Total Views
January 1, 2023	2,205,188
February 3, 2022	2,089,759

Total Categories
January 1, 2023	754
February 3, 2022	743

Total Tags
January 1, 2023	10,688
February 3, 2022	10,653

Total Posts
January 1, 2023	6,162
February 3, 2022	6,112

Progression of Top Author’s Views from 2012-2022

Updated January 1st, 2023

Author	2012	2013	2014	2015	2016	2017	2018
Aviva Lev-Ari	29,969	64,810	68,960	66,996	54,816	46,724	39,070
Larry H Bernstein	10,133	31,960	41,996	59,005	58,545	41,557	37,077
S J Williams PA	1,002	7,402	7,207	9,123	11,108	8,382	6,091
Tilda Barliya	2,854	14,453	9,761	9,762	7,402	7,784	6,859
Dr. Sudipta Saha	3,937	9,923	1,406	1,591	2,396	4,346	3,453
Dror Nir	1,979	6,901	5,162	5,666	3,423	3,595	4,071
Demet Sag Ph.D. CRA GCP		2,069	2,739	4,102	3,128	2,168	1,862
Ritu Saxena	3,445	5,392	2,455	2,190	1,289	761	820
Gail S Thornton					2,040	2,971	4,156
Irina Robu				232	515	601	896

Author	2019	2020	2021	2022	Total
Aviva Lev-Ari	34,505	52,386	46,923	31,050	536,209
Larry H Bernstein	25,089	33,432	32,629	30,080	401,503
S J Williams PA	5,735	9,523	6,345	5,619	77,537
tildabarliya	4,472	3,190	3,159	3,055	72,751
Dr. Sudipta Saha	4,517	4,023	3,276	3,423	42,291
Dror Nir	3,436	2,324	1,713	1,067	39,337
Demet Sag Ph.D. CRA GCP	1,206	1,617	1,086	717	20,694
Ritu Saxena	345	277	341	256	17,571
Gail S Thornton	3,164	2,989	2,619	2,088	20,027
Irina Robu	1,743	4,460	1,729	319	10,495

@@@@@@

Update on 3/12/2022 by Srinivas Sriram and Abhisar Anand

2/3/2022 – 2,089,759 views

7,932 comments

Content

2/3/2022 – 6,112 Posts

743 Categories

10,653 Tags

Internet Exposure Indicator (IEI) Table

Note: To calculate % change, we used the formula: % Change = (Newer – Older)/Older * 100%
All calculations were rounded to the nearest 0.01%.

INTERNET EXPOSURE INDICATORS (IEI)	% change 2/1/2021-2/3/2022	On 2/3/2022	% change 2/1/2021-7/1/2021	On 2/1/2021	On 7/1/2021
Total # of Journal Article Views	8.59% increase	2,089,759	4.10% increase	1,924,462	2,003,415
# Categories	2.06% increase	743	1.10% increase	728	736
# Tags	2.03% increase	10,653	1.00% increase	10,441	10,545
# Comments	5.41% increase	7,932	4.27% increase	7,525	7,846
TOP AUTHORS VIEWS
2012pharmaceutical	9.73% increase	508,457	5.04% increase	463,371	486,733
larryhbern	9.22% increase	373,618	4.30% increase	342,084	356,793
sjwilliamspa	8.55% increase	72,513	2.69% increase	66,800	68,594
tildabarliya	5.64% increase	69,934	2.85% increase	66,203	68,093
Dr. Sudipta Saha	6.23% increase	39,088	2.36% increase	36,797	37,665
Dror Nir	6.84% incease	38,314	4.75% increase	35,862	37,564
Demet Sag Ph.D. CRA GCP	5.10% increase	20,030	2.79% increase	19,058	19,590
ritusaxena	1.90% increase	17,330	0.96% increase	17,007	17,170
Gail S Thornton	15.63% increase	18,112	7.05% increase	15,664	16,768
Irina Robu	13.18% increase	10,208	9.34% increase	9,019	9,861

Comparison of Internet Exposure Indicators (IEI’s) With Bar Graphs

Total Views
February 1, 2021	1,924,462
February 3, 2022	2,089,759

Total Comments
February 1, 2021	7,525
February 3, 2022	7,932

Total Categories
February 1, 2021	728
February 3, 2022	743

Total Tags
February 1, 2021	10,441
February 3, 2022	10,653

Total Posts
February 1, 2021	6,001
February 3, 2022	6,112

Progression of Top Author’s Views from 2012-2022 – updated February 3rd, 2022

Author	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	Total
2012pharmaceutical	29,969	64,810	68,960	66,996	54,816	46,724	39,070	34,505	52,386	46,993	505,229
larryhbern	10,133	31,960	41,996	59,005	58,545	41,557	37,077	25,089	33,432	32,629	371,423
sjwilliamspa	1,002	7,402	7,207	9,123	11,108	8,382	6,091	5,735	9,523	6,345	71,918
tildabarliya	2,854	14,453	9,761	9,762	7,402	7,784	6,859	4,472	3,190	3,159	69,696
Dr. Sudipta Saha	3,937	9,923	1,406	1,591	2,396	4,346	3,453	4,517	4,023	3,276	38,868
Dror Nir	1,979	6,901	5,162	5,666	3,423	3,595	4,071	3,436	2,324	1,713	38,270
Demet Sag Ph.D. CRA GCP		2,069	2,739	4,102	3,128	2,168	1,862	1,206	1,617	1,086	19,977
ritusaxena	3,445	5,392	2,455	2,190	1,289	761	820	345	277	341	17,315
Gail S Thornton					2,040	2,971	4,156	3,164	2,989	2,619	17,939
Irina Robu				232	515	601	896	1,743	4,460	1,729	10,176

Update on 7/1/2021 by Srinivas Sriram and Abhisar Anand

2/1/2021 – 1,924,462 views
7/1/2021 – 2,003,639 views

7,555 comments

Content

2/1/2021 – 6,001 Posts
7/1/2021 – 6,056 Posts

736 Categories

10,545 Tags

Title		Views
Home page / Archives		765,494
Is the Warburg Effect the Cause or the Effect of Cancer: A 21st Century View?		17,365
Recent comprehensive review on the role of ultrasound in breast cancer management		16,244
Paclitaxel vs Abraxane (albumin-bound paclitaxel)		15,220
Do Novel Anticoagulants Affect the PT/INR? The Cases of XARELTO (rivaroxaban) and PRADAXA (dabigatran)		14,362
Apixaban (Eliquis): Mechanism of Action, Drug Comparison and Additional Indications		9,672
Clinical Indications for Use of Inhaled Nitric Oxide (iNO) in the Adult Patient Market: Clinical Outcomes after Use, Therapy Demand and Cost of Care		9,107
Our TEAM		6,739
Mesothelin: An early detection biomarker for cancer (By Jack Andraka)		6,623
Interaction of enzymes and hormones		6,013
Pyrroloquinoline quinone (PQQ) – an unproved supplement		5,951

Title		Views
Home page / Archives		738,554
Is the Warburg Effect the Cause or the Effect of Cancer: A 21st Century View?		17,296
Recent comprehensive review on the role of ultrasound in breast cancer management		15,696
Paclitaxel vs Abraxane (albumin-bound paclitaxel)		14,640
Do Novel Anticoagulants Affect the PT/INR? The Cases of XARELTO (rivaroxaban) and PRADAXA (dabigatran)		14,098
Apixaban (Eliquis): Mechanism of Action, Drug Comparison and Additional Indications		9,003
Clinical Indications for Use of Inhaled Nitric Oxide (iNO) in the Adult Patient Market: Clinical Outcomes after Use, Therapy Demand and Cost of Care		8,642
Our TEAM		6,672
Mesothelin: An early detection biomarker for cancer (By Jack Andraka)		6,587
Interaction of enzymes and hormones		5,747
Biochemistry of the Coagulation Cascade and Platelet Aggregation: Nitric Oxide: Platelets, Circulatory Disorders, and Coagulation Effects		5,426

Author		Views
2012pharmaceutical Aviva Lev-Ari, PhD, RN		486,733
larryhbern	Following	356,793
sjwilliamspa	Following	68,594
tildabarliya		68,093
Dr. Sudipta Saha	Following	37,665
Dror Nir		37,564
Demet Sag, Ph.D., CRA, GCP	Follow	19,590
ritusaxena	Following	17,170
Gail S Thornton	Following	16,768

Irina Robu	Following	9,861

Top Authors for all days ending 2021-02-01 (Summarized)

All Time

Author		Views
2012pharmaceutical Aviva Lev-Ari, PhD, RN		463,371
larryhbern	Following	342,084
tildabarliya		66,800
sjwilliamspa	Following	66,203
Dror Nir		36,797
Dr. Sudipta Saha	Following	35,862
Demet Sag, Ph.D., CRA, GCP	Follow	19,058
ritusaxena	Following	17,007
Gail S Thornton	Following	15,664

Irina Robu	Following	9,019

Read Full Post »

@ PharmaceuticalIntelligence.com Top Articles by Views >500 for 365 days ending 2020-12-29 (Summarized) – #1: Coronavirus, SARS-CoV-2 Portal

Posted in LPBI Management on December 29, 2020| Leave a Comment »

@ PharmaceuticalIntelligence.com Top Articles by Views >500 for 365 days ending 2020-12-29 (Summarized) – #1: Coronavirus, SARS-CoV-2 Portal

Reporter: Aviva Lev-Ari, PhD, RN

Contributions to 2020 Article Views

Home Page	76698
Coronavirus Portal	2844
Larry	17347
Aviva	11696
Saha	3262
Ofer	1745
D. Nir	1689
Gail	1384
Tilda	1025
Irina	810

	Original
Article Title	Views July 2nd, 2021	UPDATED Views December 31, 2022
Home page / Archives	765,595	824,332
Is the Warburg Effect the Cause or the Effect of Cancer: A 21st Century View?	17,365	17,553
Recent comprehensive review on the role of ultrasound in breast cancer management	16,246	17,163
Paclitaxel vs Abraxane (albumin-bound paclitaxel)	15,227	17,927
Do Novel Anticoagulants Affect the PT/INR? The Cases of XARELTO (rivaroxaban) and PRADAXA (dabigatran)	14,370	14,703
Apixaban (Eliquis): Mechanism of Action, Drug Comparison and Additional Indications	9,678	11,255
Clinical Indications for Use of Inhaled Nitric Oxide (iNO) in the Adult Patient Market: Clinical Outcomes after Use, Therapy Demand and Cost of Care	9,111	10,799
Our TEAM	6,740	6,918
Mesothelin: An early detection biomarker for cancer (By Jack Andraka)	6,623	6,703
Interaction of enzymes and hormones	6,017	6,582
Pyrroloquinoline quinone (PQQ) – an unproved supplement	5,956	8,954

Archive for the ‘LPBI Management’ Category

We Celebrate TEN Years of Excellence, LPBI Group: 4/2012 – 4/2022

Five Bilingual BioMed e-Series – 37 volumes

2022 Update from LPBI Group

2022 Update from LPBI Group

Abbreviated electronic Table of Contents (eTOCs) of each Volume in the EIGHTEEN-Volume BioMed e-Series

Aviva Lev-Ari, PhD, RN

We plan to MINT as NFTs several of LPBI Group’s IP Asset Classes, such as

A stream of Ten INNOVATIONS in the Life of LPBI since

Share this:

Like this:

Analytics for @AVIVA1950 Tweeting at #EmTechDigital

TWEET HIGHLIGHTS

Top Tweet earned 122 impressions

Top mention earned 7 engagements

Share this:

Like this:

Equity Sharing Calculation: A Scoring System for Author’s (a) Total Articles (single author) and (b) multiple authors (c) Total Articles Views (d) Author’s Proportion of own articles views in the Top 14 Journal articles by Views and (e) External Citations (f) Influencer on Twitter

LPBI Group had developed a Scoring System for attribution of Equity Sharing in IP Asset Class I: Journal articles to Top Authors by number of articles published and by Views at all time for all articles published in the Journal

(f) Influencer ranking at World Medical Innovation Forum ARTIFICIAL INTELLIGENCE in MEDICINE

(e) External Citations

(a) Author’s Total Articles (single author)

(b) Author’s multiple authors articles

(c) Author’s Total Articles Views

(d) Author’s Proportion of own articles views in the Top 14 Journal articles by Views

(e) External Citations – See UPDATED on 5/24/2022, above

(f) Global Score across all the parameters

Share this:

Like this:

Analytics for e-Reputation based on LinkedIn 1st Degree Connections, +7,500 of LPBI Group’s Founder, 2012-2022: An Intangible Asset – Connections’ Position Seniority & Biotech / Pharma Focus

Aviva Lev-Ari, PhD, RN

Additional parameters of e-Reputation as an intangible asset for LPBI Group’s Founder and for LPBI Group as a Firm are analyzed in other articles, see the following List of Links:

Summary and Conclusions:

Founder’s LinkedIn 1st Degree Connections, N = +7,500

Marquee Corporations:

Their Leaders are 1st Degree Connections of LPBI Group’s Founder

Corporate Leaders are 1st Degree Connections of LPBI Group’s Founder

Industry Focus of the Marquee Corporations who’s Leaders are

1st Degree Connections to LPBI Group’s Founder

In Highest Frequency of Leading Positions we find the C-Suite

Total

7,485

Share this:

Like this:

NCCN Shares Latest Expert Recommendations for Prostate Cancer in Spanish and Portuguese

Please see LPBI Group’s efforts in medical text translation and Natural Language Processing of Medical Text at

Share this:

Like this:

Standard Operating Procedures for Updating the Map of LPBI India

Share this:

Like this:

Standard Operating Procedures for Text to Audio Conversion – How to create a Podcast and Embed it on a Post or on a Page

Converting an Article to a Podcast

Embedding a Podcast into an article

Editing a previously published podcast

Share this:

Like this:

Standard Operating Procedures for creating a DropBox Account

Share this:

Like this:

Top Articles by Views – Updated on 12/31/2022

Internet Exposure Indicator (IEI) Table

Progression of Top Author’s Views from 2012-2022

Updated January 1st, 2023

@@@@@@

Content

Top Articles by Views 2/1/2021 vs 7/1/2021

Line Graph Depicting Top Authors Progression by Views Ending 2021-07-01Date of Production: 2021-07-01

Top Posts for all days ending 2021-07-01 (Summarized)Date of Production: 2021-07-01

All Time

Top Posts for all days ending 2021-02-01 (Summarized)

All Time

Top Authors by Views 2/1/2021 vs 7/1/2021

Top Authors for all days ending 2021-07-01 (Summarized)Date of Production: 2021-07-01

All Time

Top Authors for all days ending 2021-02-01 (Summarized)

All Time

Share this:

Like this:

@ PharmaceuticalIntelligence.com Top Articles by Views >500 for 365 days ending 2020-12-29 (Summarized) – #1: Coronavirus, SARS-CoV-2 Portal

Line Graph Depicting Top Authors Progression by Views Ending 2021-07-01
Date of Production: 2021-07-01

Top Posts for all days ending 2021-07-01 (Summarized)
Date of Production: 2021-07-01

Top Authors for all days ending 2021-07-01 (Summarized)
Date of Production: 2021-07-01